NCT06782581 CARE Study: Cancer, Asian Americans, and Relationship Enrichment
| NCT ID | NCT06782581 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fox Chase Cancer Center |
| Condition | Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 186 participants |
| Start Date | 2024-08-06 |
| Primary Completion | 2027-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 186 participants in total. It began in 2024-08-06 with a primary completion date of 2027-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to increase a sense of autonomy, competence, and connectedness, each of which have been shown to be associated with psychological benefits according to self-determination theory.
Eligibility Criteria
Inclusion Criteria for Patients: 1. self-identifies as Asian American or Asian 2. males or females ages 21-80 years 3. within 2 years of any cancer diagnosis or stage 4 cancer diagnosis 4. actively undergoing surgery or systemic therapy (e.g., chemotherapy, radiation, immunotherapy) or within the past 6 months, 5. able to identify a caregiver (e.g., spouse) who lives in the same household or see at least 3 times per week 6. able to read, write, and speak English (i.e., English proficient; EP) or Mandarin/simplified Chinese. Exclusion Criteria for patients: 1. life expectancy less than 6 months in the opinion of the primary physician 2. inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status), 3. major thought disorder (e.g., schizophrenia or bipolar \[patient records or self-disclosure\]). Inclusion Criteria for Caregivers: 1. identifies as Asian American or Asian, 2. patient considers them to be caregiver 3. English proficient or Mandarin Chinese proficient 4. access to computer/phone, internet, and web browser. Exclusion Criteria for Caregivers: 1. unwilling or unable to participate in the study for any reason, 2. under the age of 18.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06782581 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06782581 currently recruiting?
Yes, NCT06782581 is actively recruiting participants. Contact the research team at Lilian.Shin-Cho@fccc.edu for enrollment information.
Where is the NCT06782581 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06782581 clinical trial?
NCT06782581 is sponsored by Fox Chase Cancer Center. The trial plans to enroll 186 participants.